Glycosaminoglycan
10 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
2
Deaths Reported
2000.0%
Death Rate
Active Ingredients
Glycosaminoglycan
Administration Routes
UnknownIntramuscularSubcutaneous
Species Affected
Dog 10
Most Affected Breeds
Retriever - Labrador 4
Retriever - Golden 2
Shepherd Dog - German 2
Beagle 1
Schnauzer - Miniature 1
Most Reported Reactions
Limb weakness 4
Weight loss 4
Lethargy (see also Central nervous system depression in Neurological) 4
Lameness 4
Abnormal radiograph finding 3
Lack of efficacy - NOS 2
Elevated serum alkaline phosphatase (ALP) 2
Partial lack of efficacy 2
Incoordination 2
Heavy breathing 2
Panting 2
Laryngeal paralysis 2
Outcome Breakdown
Ongoing
5 (50.0%)
Outcome Unknown
2 (20.0%)
Euthanized
2 (20.0%)
Recovered/Normal
1 (10.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.